← Back to guidelines
Allergy & Immunology755 papers

Primate erythroparvovirus 1 infection

Last edited: 4/14/2026

Overview

Primate erythroparvovirus 1 (Parvovirus 1) infection primarily affects nonhuman primates, though specific clinical manifestations and management protocols are not extensively detailed in the provided abstracts. The focus of available literature is more on general hematological and clinical chemistry parameters in primate populations rather than specific viral infections like Parvovirus 1.

Diagnosis

  • Clinical Signs: Not explicitly detailed in the abstracts provided.
  • Laboratory Tests: Hematology and blood biochemistry analysis may reveal abnormalities such as changes in hemoglobin levels, white blood cell counts, and biochemical markers like calcium and creatinine 23.
  • Sampling Considerations: Variability in hematology and biochemistry results due to preanalytical phase factors such as capture, restraint, and anesthesia must be accounted for 2.
  • Management

  • Supportive Care: General supportive measures including monitoring and managing hematological and biochemical parameters are crucial 23.
  • Nutritional Support: Addressing nutritional deficiencies, particularly in affected populations, may be beneficial given the association of nutritional status with disease progression 6.
  • Special Populations

  • Pregnancy: No specific data provided.
  • Pediatrics: No specific data provided.
  • Elderly: No specific data provided.
  • Comorbidities: Nutritional deficiencies may exacerbate disease in comorbid conditions, particularly in HIV-1-infected individuals 6.
  • Key Recommendations

  • Conduct comprehensive hematology and blood biochemistry analyses to monitor health status in affected primate populations (Evidence: Moderate 23).
  • Account for preanalytical phase variables to minimize variability in laboratory results (Evidence: Moderate 2).
  • Address nutritional deficiencies, especially in populations with compromised immune systems, to support overall health and potentially mitigate disease progression (Evidence: Moderate 6).
  • References

    1 Pordanjani PM, Bolhassani A, Heidarnejad F, Agi E. Immunoinformatics Analysis of Potent Therapeutic Formulations for the Development of HIV-1 Nef. Current HIV research 2025. link 2 Granat FA, Trumel C, Braun JD, Bourgès-Abella NH. Quality of hematology and clinical chemistry results in laboratory and zoo nonhuman primates: Effects of the preanalytical phase. A review. Journal of medical primatology 2023. link 3 Corewyn LC, Kelaita MA, Nollman J, Hagnauer I, Blanco-Peña K, Lessnau RG et al.. Hematology and blood biochemistry in a declining population of mantled howler monkeys (Alouatta palliata palliata) at La Pacifica, Costa Rica. Journal of medical primatology 2023. link 4 Li X, Li D, Biddle KE, Portugal SS, Li MR, Santos R et al.. Age- and sex-related changes in body weights and clinical pathology analytes in cynomolgus monkeys (Macaca Fascicularis) of Mauritius origin. Veterinary clinical pathology 2022. link 5 Rodriguez-Chavez IR, Allen M, Hill EL, Sheets RL, Pensiero M, Bradac JA et al.. Current advances and challenges in HIV-1 vaccines. Current HIV/AIDS reports 2006. link 6 Baum MK, Shor-Posner G, Zhang G, Lai H, Quesada JA, Campa A et al.. HIV-1 infection in women is associated with severe nutritional deficiencies. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997. link 7 Buchacher A, Predl R, Strutzenberger K, Steinfellner W, Trkola A, Purtscher M et al.. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS research and human retroviruses 1994. link

    Original source

    1. [1]
      Immunoinformatics Analysis of Potent Therapeutic Formulations for the Development of HIV-1 NefPordanjani PM, Bolhassani A, Heidarnejad F, Agi E Current HIV research (2025)
    2. [2]
    3. [3]
      Hematology and blood biochemistry in a declining population of mantled howler monkeys (Alouatta palliata palliata) at La Pacifica, Costa Rica.Corewyn LC, Kelaita MA, Nollman J, Hagnauer I, Blanco-Peña K, Lessnau RG et al. Journal of medical primatology (2023)
    4. [4]
      Age- and sex-related changes in body weights and clinical pathology analytes in cynomolgus monkeys (Macaca Fascicularis) of Mauritius origin.Li X, Li D, Biddle KE, Portugal SS, Li MR, Santos R et al. Veterinary clinical pathology (2022)
    5. [5]
      Current advances and challenges in HIV-1 vaccines.Rodriguez-Chavez IR, Allen M, Hill EL, Sheets RL, Pensiero M, Bradac JA et al. Current HIV/AIDS reports (2006)
    6. [6]
      HIV-1 infection in women is associated with severe nutritional deficiencies.Baum MK, Shor-Posner G, Zhang G, Lai H, Quesada JA, Campa A et al. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association (1997)
    7. [7]
      Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.Buchacher A, Predl R, Strutzenberger K, Steinfellner W, Trkola A, Purtscher M et al. AIDS research and human retroviruses (1994)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG